Previous phase

Loss of Exclusivity Planning

Planning for life after patent

Once a drug’s patent has expired, it does not mean the end of its profitability. After all, there are a number of strategies – from maintaining brand equity to launching your own generic alternative – that could still lead to a significant amount of revenue.

That said, doing so requires a good amount of insight and planning, including surveying the market and completing competitive simulations.

Services We Recommend at
the LOE Phase


Many see compendia databases as just a pricebook, but they’re so much more. In fact, an incorrect classification can mean a failed launch.

Market Access

Just as with launching a new product, managing a product’s loss of exclusivity (LOE) requires strategic planning and oversight.

Market Intelligence

Our Competitive Simulations are your key to deeper competitor insight and a smarter business development strategy.
Our extensive experience monitoring and assessing all therapeutic categories allows us to provide insights to support licensing and acquisition decisions.
Whether your drug is going off-patent soon or you are developing a new agent, gaining insight into other generics and biosimilars in development is critical.

We’re here to support your success from clinical to commercial – and beyond.

How can we help you today?